South Carolina man chooses to die by lethal injection instead of electric chair or firing squad
A South Carolina inmate who has spent more than half his life on death row has chosen to die by lethal injection instead of ...
Community Impact Newspaper4d
IV therapy has risen in popularity in Central Texas. What is it and how does it work?
IV therapy administers vitamins, minerals and nutrients directly into the bloodstream for wellness benefits. (Courtesy Adobe ...
Cure Today5d
Delving into Subcutaneous Versus Intravenous Opdivo in Solid Tumors
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...
India Today NE on MSN1d
Tripura bans use of 2023 IV fluids from West Bengal pharmaceutical over safety concerns
The Health and Family Welfare Department in Tripura has issued an order prohibiting the use of any IV fluids manufactured in ...
Armed robbery in Revesby2d
IV Protamine Cuts Compression Time Post Coronary Angio
Intravenous application of protamine after coronary angiography via dTRA can significantly shorten the time of postoperative ...
Cure Today10d
Understanding the Benefit of Subcutaneous Versus IV Opdivo in Patients With Solid Tumors
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...
MassDevice3d
BD increases U.S. syringe, IV catheter manufacturing
BD (NYSE: BDX) announced today that it plans to invest further in U.S. manufacturing to add capacity for certain critical ...
oncnursingnews2dOpinion
Opinion: Subcutaneous Nivolumab Offers an Effective Alternative to Intravenous Administration
Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...
Tripura bans IV fluids made by West Bengal Pharmaceutical
Agartala: Tripura govt on Friday announced an immediate ban on the use of IV fluids manufactured in 2023 by West Bengal Pharmaceutical, citing safety .
The American Journal of Managed Care10d
Subcutaneous Ocrelizumab Well Tolerated in Patients With MS
Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...